A large cohort of patients around the world diagnosed with myelofibrosis (aka bone marrow cancer) will soon be able to…
How does a company with a lead asset cancer drug also get into dermatology? What does blood cancer and keloid…
Clinical stage pharmaceutical company Pharmaxis (PXS: ASX) is full steam ahead with their Phase 2 clinical trial for flagship drug,…
In the wake of their oversubscribed capital raising effort, clinical stage pharmaceutical company Pharmaxis (ASX: PXS) is forging ahead with…
Promising early study results released today by clinical stage drug development company Pharmaxis (ASX: PXS), should be a reason for…